Arthur David J. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Mar 9, 2022
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-03-03$0.39/sh+139,488$54,540→ 249,674 total
Footnotes (1)
- [F1]The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.